Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent in the US
Loteprednol Etabonate Ophthalmic Suspension (RLD Lotemax) had estimated annual sales of $ 55 million in the US (IQVIA MAT May…
Author
Panel Discussion: Accelerating OSD innovation: From R&D to market
FDD Conclave 2025 | 13th June 2025 | Hyderabad
Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart
KIRSTY will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and…
Agilent launches InfinityLab Pro iQ Series mass detectors in India
The detectors manage workflows, including impurity profiling, biomolecule characterisation, trace-level detection, and mass-based…
Rethinking trust: what pharma can learn from Indian corner shops
Anagha Shirur - Adjunct Faculty, K J Somaiya Institute of Management, expresses how lessons from the kirana shops may offer…
Keynote Address by Dr Pavan Bhat, CEO, Inventia Healthcare
Injectable Innovations Conclave 2025 | 11th July 2025 | Hyderabad
Panel Discussion: Redefining delivery – Innovations transforming injectable therapies
Injectable Innovations Conclave 2025 | 11th July 2025 | Hyderabad
Mr Vidwans Rajendra Ramachandra, Senior Consultant – GMP, QA, in Sterile, Non-sterile dosage…
Injectable Innovations Conclave 2025 | 11th July 2025 | Hyderabad
Mr Nitin Khaladkar, Head R&D (Rubber stopper), Bharat Rubber Works
Injectable Innovations Conclave 2025 | 11th July 2025 | Hyderabad